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Abstract
Paternal obesity is now clearly associated with or causal of impaired embryo and fetal development and reduced pregnancy
rates in humans and rodents. This appears to be a result of reduced blastocyst potential. Whether these adverse embryo
and fetal outcomes can be ameliorated by interventions to reduce paternal obesity has not been established. Here, male
mice fed a high fat diet (HFD) to induce obesity were used, to determine if early embryo and fetal development is improved
by interventions of diet (CD) and/or exercise to reduce adiposity and improve metabolism. Exercise and to a lesser extent
CD in obese males improved embryo development rates, with increased cell to cell contacts in the compacting embryo
measured by E-cadherin in exercise interventions and subsequently, increased blastocyst trophectoderm (TE), inner cell
mass (ICM) and epiblast cell numbers. Implantation rates and fetal development from resulting blastocysts were also
improved by exercise in obese males. Additionally, all interventions to obese males increased fetal weight, with CD alone
and exercise alone, also increasing fetal crown-rump length. Measures of embryo and fetal development correlated with
paternal measures of glycaemia, insulin action and serum lipids regardless of paternal adiposity or intervention, suggesting
a link between paternal metabolic health and subsequent embryo and fetal development. This is the first study to show that
improvements to metabolic health of obese males through diet and exercise can improve embryo and fetal development,
suggesting such interventions are likely to improve offspring health.
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Introduction
Worldwide obesity is epidemic, with 200 million men and
300 million women over the age of 20 currently classified as obese
[1]. While, maternal obesity is well established to adversely affect
the oocyte and negatively impact the establishment of pregnancy
[2–4], there is now mounting evidence that paternal obesity is also
implicated in gamete health and pregnancy outcomes [5–7]. An
overweight or obese male with a female partner of normal body
mass index (BMI), has an increased odds ratio for a longer time to
conceive, compared with couples where both are of normal weight
[8,9]. Studies of couples undergoing assisted reproductive tech-
nology (ART) have established that male obesity is associated with
reduced pregnancy rates and increased pregnancy loss [5–7]. This
phenomenon seems to be as a result of reduced sperm binding and
fertilisation rates, as well as impaired blastocyst development
[5,10,11].
Similarly, in experimental rodent models of paternal obesity
where males are fed a high fat diet (HFD) to induce obesity with or
without impaired glucose control, perturbed sperm function, with
reduced sperm motility, increased oxidative stress and DNA
damage are seen [12–14]. When these obese males were then
mated to normal weight females, they exhibited impaired embryo
development, and reduced implantation and live birth rates
[11,15,16].
Recently it has been established that exercise and caloric
restriction in obese males can reduce adiposity and improve sexual
function. One study in humans examined 43 obese men who were
placed on a 14 week diet and exercise weight loss program and
demonstrated improved total sperm count and morphology in
those men who lost the greatest weight [17]. Gastric bypass
surgery and weight loss in obese men have shown similar results
with improvements to sex hormone profiles and sexual function
[18]. Additionally, diet and exercise interventions in a mouse
model of male obesity induced by a HFD has recently shown that
sperm function was highly correlated with their metabolic health,
with normalisation of serum glucose, cholesterol, triglycerides, free
fatty acids (FFA) and insulin, associated with restoration of sperm
motility, morphology, oxidative stress, DNA damage and sperm
binding [13].
Thus weight loss strategies have shown promise in restoring
sperm quality of obese males in both rodents and humans, but no
PLOS ONE | www.plosone.org 1 August 2013 | Volume 8 | Issue 8 | e71459
studies to date have determined whether weight loss and improved
metabolic state in obese males can reverse their associated
impaired embryo health and pregnancy outcomes. We have
therefore induced obesity in male mice with additional diet and/or
exercise interventions, previously reported to reduce adiposity,
improve metabolic state and sperm function [13] and determined
if early embryo, fetal development and pregnancy rate can be
restored. We hypothesise, that weight loss and or an improvement
to metabolic health via diet and exercise interventions in obese
males will improve subsequent embryo and fetal health similar to
levels of normal weight males.
Methods
Ethics Statement
This study was carried out in strict accordance with the
Australian code of practice for the care and use of animals for
scientific purposes. The use and care of all animals used in the
study was approved by the Animal Ethics Committee of The
University of Adelaide.
Animals and Diet
Five week old male C57BL6 mice (n = 40) were randomly
assigned to one of two diets for an initial period of 9 weeks: 1)
control diet (CD) (SF04-057; Specialty Feeds, Perth, Australia,
(Table S1); or 2) a high fat diet (HFD) high in fat and nutrient
matched (SF00-219; Specialty Feeds, Perth, Australia, Table S1).
Diets used in the study have been previously shown to increase
adiposity in male mice, without affecting glucose tolerance after
9 weeks [15,19–21]. After the initial feeding period, males
allocated to the HFD were further allocated to one of the
following interventions for a further period of 9 weeks: 1)
continuation of a HFD (HH) (n= 8); 2) change to a CD (HC)
(n = 8); 3) continuation of a HFD with exercise (HE) (n = 8); 4)
change to a CD with exercise (HCE) (n = 8). Mice allocated to the
CD during the initial feeding period were also fed a CD during the
intervention period as a baseline control (CC) (n = 7). These
interventions have previously been shown to reduce adiposity in
those obese males that undergo diet interventions and to improve
metabolic parameters in those obese males that undergo exercise
and or diet interventions [13]. Animals were individually housed
for the entire study and fed ad lib.
Exercise Intervention (Swimming)
The swimming exercise regime was followed as previously
described [13]. Briefly male mice were placed into tank containing
warm water at a constant temperature of 32uC61uC to swim
freely for the set time period. For the first 2 weeks mice swam for
3615 min periods over 7 days with one days rest in between
swimming sessions [22]. This allowed time for the mice to become
accustomed to exercise regime and the swimming tank. For the
remainder of the intervention (6 weeks) mice swam for 3630 min
training sessions each week with at least one days rest in between
swimming sessions to simulate light exercise. This imposes light
exercise in comparison with a moderate training program in which
mice freely swam for 60 min, 5 days a week, for 18 weeks [23].
Body Composition
Individual body weights of the males were recorded weekly
during the pre and post intervention periods. At pre intervention
week 9 (14 weeks of age) and at the end of intervention week 9
(23 weeks of age) whole body composition of lean mass, bone
density, adiposity were measured by a dual-emission X-ray
absorptiometry machine (DEXA) (Piximus, Ge Lunar, Wisconsin,
USA) as previously described [13]. Additionally, selected organs
(liver, kidneys and pancreas) and reproductive tissues (gonadal fat,
testes, seminal vesicles) were collected and weighed at the end of
the intervention period (intervention week 9, 23 weeks of age) after
males were humanely killed by cervical dislocation post cardiac
puncture.
Serum Metabolite Analysis
Blood was sampled from the tail vein after six hours fasting, at
the end of pre intervention week 9 (14 weeks of age) and post
intervention week 9 (23 weeks of age), and blood glucose was
measured by a glucometer (Hemocue, Angelholm, Sweden). At the
end of the intervention period (intervention week 9, 23 weeks of
age), a fasted blood sample was obtained via cardiac puncture
under anaesthetic with 2% Isoflurane (1-chloro-2,2,2-trifluor-
oethyldifluoromethylether) (Veterinary Companies of Australia,
Kings Park, Australia) (44 hr post swimming training for exercise
intervention mice) for measurement of serum cholesterol, FFAs,
triglycerides and leptin. Serum cholesterol, FFAs and triglycerides
were measured by enzymatic analysis on a Hitachi 912 automated
sample system, as previously described [13] and serum leptin levels
were determined using a mouse leptin ELISA kit (Cat# 90030) as
per the manufacturer’s instructions (Crystal Chem Inc, Downer
Grove, USA).
Intraperitoneal Glucose Tolerance Test (GTT) and Insulin
Tolerance Test (ITT)
A GTT and ITT was performed at the beginning of
intervention week 6 and 7 respectively (20 and 21 weeks of age
respectively) after 6 h of fasting by intra-peritoneal (IP) injection of
2 g/kg of 25% D-glucose solution for GTT or during a fed state
by IP injection of 0.75 IU of human insulin (ActapidH, Novo
Nordisk, Bagsvaerd, Denmark) for a ITT. GTT and ITT were
performed on rest days for exercise intervention mice (HE and
HCE). Glucose concentrations were measured using a glucometer
(Hemocue, Angelholm, Sweden) at time points 0 (pre-bolus basal),
15, 30, 60 and 120 min on whole blood collected from the tail vein
through a tail cut. Data were expressed as mean blood glucose
concentration per group as area under curve (AUC) for glucose
and area above the curve (AAC) for insulin.
Embryo Collection
3–4 week old C57BL6 female mice who were fed standard
chow (Table S1) were given an intraperitoneal (IP) injection of 5
IU Pregnant Mare’s Serum Gonadotropin (PMSG) (Folligon,
Invervet, Bendigo, Australia), followed 48 h later with an IP
injection of 5 IU human Chorionic Gonadotropin (hCG) (Pregnyl,
Organon, Sydney, Australia) to induce ovulation as per [24,25].
Following the hCG injection female mice were individually placed
with a C57BL6 male between intervention weeks 7–9 (21–
23 weeks of age). Each male (n = 8 HH, HC, HE, HCE and n= 7
CC) had the opportunity to mate with 6 super ovulated females at
independent times. Successful mating was assessed the following
morning by the presence of a vaginal plug. There was no
significant difference between mating rates between groups.
Successful mating occurred in 6 HH and HCE males and 7 CC,
HC and HE males. Each individual male produced between 30 to
80 zygotes from 2–4 females (Table S2). Males that under went
swimming exercise (HE and HCE) were mated on alternate days
to exercise and each male from all treatment groups had a least
1 days rest in between mating. At 22–24 h post hCG female mice
were humanly killed by cervical dislocation and, cumulus enclosed
zygotes were collected and placed in MOPS at 37uC and denuded
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of cumulus cells by 1 min incubation with 0.5 mg/ml hyaluron-
idase. Zygotes were washed twice in MOPS and once in G1
medium before culture in G1 media [26].
Embryo Culture
Embryos were cultured in groups of 10 in 20 ml drops of G1
under paraffin oil (Merek, New Jersey, USA) for 48 h at 37uC in
5% O2, 6% CO2 and 89% N2. Embryos were then washed and
cultured in medium G2 for a further 48 h to the blastocyst stage.
On-time embryo development was assessed at 43 h post hCG (day
2, cleavage), 67 h post hCG (day 3, compaction), 98 h post hCG
(day 4, early blastocyst) and 115 h post hCG (day 5, late
blastocyst). All embryo culture dishes were prepared 4 h prior to
embryo culture to allow for gassing and temperature equilibration
with 24 replicate experiments performed.
E-cadherin in Embryos
The localisation of E-cadherin in embryos was determined by a
modified immunofluorescence protocol as previously described
[27]. Briefly, 8-cell embryos were collected at 67 h post hCG, fixed
in 4% paraformaldehyde overnight and stored in 0.1 M glycine.
Embryos were permeabilised in 0.25% TritonX-100 (PBS-TX) for
45 min and placed into blocking solution (1:10 donkey serum) and
primary antibody (1:200, Rabbit anti E-cadherin, Abcam, Cam-
bridge, UK; ab53033) at 4uC overnight. The following day
embryos were washed through PBS-TX and placed into secondary
antibody (1:200, Donkey anti Rabbit Alex 488, Life Technologies,
Invitrogen, Mulgrave, Australia; A-21206) at 37uC for 2 h.
Following another wash in PBS-TX embryos were placed in
0.25 mg/ml of propidium iodine (PI) for 5 min to stain the
nucleus. For a negative control the primary antibody was omitted
from the reaction. Embryos were loaded in glycerol and allowed to
settle to the bottom before been imaged blinded by the same
individual using confocal microscopy. E-cadherin localisation were
determined by characterising if 8-cell embryos had either 1 of 3
staining patterns observed during confocal z-sectioning; 1) E-
cadherin at cell to cell contacts (Fig. 1A), 2) E-cadherin at both cell
to cell contacts and cytoplasm (Fig. 1B) and 3) E-cadherin only in
the cytoplasm (Fig. 1C). The numbers of embryos for each staining
pattern for each treatment group were expressed as a percentage.
Blastocyst DNA Damage
The number of apoptotic cells in each blastocyst were
determined at day 5 of embryo development (115 h post hCG)
using TUNEL (Terminal deoxynucleotidyl Transferase Biotin-
dUTP Nick End Labelling) (In Situ Cell Death detection kit,
Roche Molecular Biochemicals, Indianapolis, IN) as described
previously [28]. The numbers of apoptotic cells were expressed as
a percentage of total cell number for each blastocyst. A positive
control was used where blastocyst were incubated in the presence
of DNase I (Invitrogen, Mulgrave, Australia) and a negative
control where blastocysts were incubated only in the fluorescent
buffer.
Assessment of ICM, Trophectoderm and Epiblast Cell
Number (Nanog and Oct4 Staining)
To determine the number of epiblast cells within the ICM, day
5 blastocysts were further grown in the above culturing system for
an additional 24 hours (Day 6, 139 h post hCG) to allows time for
epiblast cells to be detected in the ICM by Nanog and Oct4
antibodies and stained using our previously published method
[29]. Briefly blastocysts were fixed in 4% paraformaldehyde
overnight at 4uC and neutralised in 0.1 M glycine. Blastocysts
were permeabilised in PBS-TX for 15 min at room temperature
(RT) and blocked overnight at 4uC in 10% normal donkey serum
(Sigma, D9663). Blastocysts were then incubated in primary
antibodies rabbit anti Nanog (Cozmo Bio, Tokyo, Japan; REC-
RCAB0002P) (1:200) and goat anti Oct4 (Santa Cruz, California,
USA; SC-8628) (1:100) for 1K h at 37uC. Following washing in
PBS-TX blastocysts were incubated in secondary antibodies
donkey anti rabbit Alexa 488 (Life Technologies, Invitrogen,
Mulgrave, Australia; A-21206) (1:100) and donkey anti goat Alexa
594 (Life Technologies, Invitrogen, Mulgrave, Australia; A-11058)
(1:100) for 2 h at RT. To further determine cell nuclei blastocyst
were incubated in DAPI for 2–3 min at RT before being loaded in
glycerol and counted using fluorescent microscopy. Total cell
number (TCN) was assessed by nuclei stained DAPI; inner cell
mass (ICM) cell number nuclei also stained positive for Oct4, and
epiblast cell number nuclei additionally stained positive for Nanog.
Trophectoderm cell number (TE) was determined by subtracting
ICM from TCN. For a negative control the primary antibodies
were omitted from the reaction.
Embryo Transfer
Morphological similar expanded or hatched blastocysts (115 h
post HCG) were transferred into day 4 pseudo pregnant 10 week
old Swiss female mice (21 day asynchronous). Embryos from each
treatment were randomly allocated to each uterine horn with each
mother having six blastocysts from 2 different treatment groups
(transferred to each uterine horn). Twelve to eighteen embryos
were transferred into 2–3 mothers per father from 5 HE and HCE
and 6 CC, HH and HC males. Mothers were maintained on
standard chow (Table S1) until day 18 of pregnancy. On day 18 of
pregnancy, mothers were humanely killed by cervical dislocation
and implantations, numbers of fetuses and resorptions were
determined per uterine horn for calculation of implantation rates,
Figure 1. E-cadherin Staining Patterns. A E-cadherin localisation to
cell to cell contacts. B E-cadherin localisation to both cell to cell
contacts and cytoplasm. C E-cadherin localisation to the cytoplasm.
Green images represent E-cadherin staining, red images represent
nuclear staining and merge images represent a compression of both.
Pictures are representative of a single z-section through embryos.
doi:10.1371/journal.pone.0071459.g001
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percentage of fetuses and percentage of fetuses per total number of
implantations. Fetuses and placentas were dissected and removed
of connective tissue, umbilical cords and maternal arterial space
(apostrophe) for placentas. Crown rump length and weights of
resultant fetuses and placentas were measured.
Statistical Analysis
All data were expressed as mean 6 SEM and checked for
normality using a Kolmogorov-Smirnov test and equal variance
using a Levene’s test. All statistical analysis was performed in SPSS
(SPSS Version 18, SPSS Inc., Chicago, USA). A p value ,0.05
was considered to be significant.
Weight gain data, body composition and DEXA body
composition in our founder males were analysed by a one way
ANOVA with an LSD post hoc test.
Embryo cell development, embryo DNA damage and
embryo cell number were expressed per father and analysed by
a one way ANOVA with a LSD post hoc test between groups.
Nanog staining was analysed by Mann-Whitney U test between
groups as the data are not normally distributed.
Fetal weight and size, placental weight and size and
fetal to placental weight ratios there was no interaction
between litter size and fetal weights and therefore fetuses and
placentas were expressed per father and analysed by a univariate
generalized linear model with a LSD post hoc test between groups.
Cohort of founders was fitted as a covariate.
Implantation rates and E-cadherin staining patterns
were analysed by a Chi Square between groups.
Correlations between founder’s serummetabolites and
embryo and fetal health were determined by a Pearson’s Rho
test and expressed as the correlation coefficient (CCO) along with
its corresponding p value and number of observations. To
determine if paternal adiposity was contributing to the correlations
of serum metabolites to embryo and fetal health additional partial
correlations controlling for paternal adiposity were also included.
Results
Effect of Diet and Exercise on Embryo Development
There was no change in cleavage rates to the 2-cell stage
between any of the treatment groups (p.0.05, Table 1). Males fed
a HH produced a decreased number of embryos at the 8-cell/
compacting stage on day 3 compared with CC (p,0.05, Table 1),
with combined diet and exercise intervention (HCE) advancing
development to the 8 cell/compacting stage compared with HH
and HC (p,0.05, Table 1). Diet alone (HC) or exercise alone (HE)
did not alter development to the 8-cell/compacting stage,
compared with HH (p.0.05, Table 1). This advancement in
embryo development from CC males was also evident on day 4
with reduced numbers of early blastocysts contributing to total
blastocyst numbers compared with HH males (p,0.05, Table 1).
All interventions (HC, HE and HCE) displayed advanced
blastocyst development on day 4 with increasing numbers of
hatching blastocysts compared with HH (p,0.05, Table 1) and a
decrease in expanded blastocysts compared with CC (p,0.05,
Table 1). By day 5 of embryo development exercise interventions
(HE and HCE) maintained their increased numbers of hatching
blastocysts compared with HH (p,0.05, Table 1). There was no
difference between total blastocysts, expanded blastocysts or
hatching blastocysts between the remaining treatment groups
(HC, CC and HH) indicating a slower rate of development in
embryos from HH males, rather than a failure to develop.
Effect of Diet and Exercise on Blastocyst Cell Numbers
and DNA Damage
Blastocysts produced by males from the HH group had lower
total cell numbers on day 5, compared with those of CC males
(p,0.05, Table 2). All interventions (HC, HE and HCE) increased
total blastocyst cell number on day 5, compared with HH
(p,0.05, Table 2), restoring this to be comparable with the CC
group (p.0.05, Table 2). This reduction in cell number from the
HH was not as a result from increased apoptosis as there was no
difference in the number or percentage of TUNEL positive cells in
the blastocyst across groups (p.0.05, Table 2).
Effect of Diet and Exercise on Epiblast, ICM and
Trophectoderm Cell Number
Embryos were further cultured for an additionally 24 hrs (day 6)
to allow time for epiblast cells to be detected in the ICM by Nanog
and Oct4 antibodies. All interventions (HC, HE and HCE) and
CC had increased cell numbers (TCN and TE) compared with
HH, similar to that observed on day 5 (p,0.05, Table 2). ICM
and epiblast cell numbers were increased in blastocysts from the
CC males compared with HH (p,0.05, Table 2) with combined
diet and exercise interventions (HCE) also having an increase ICM
cell numbers compared with HH (p,0.05, Table 2). Diet alone
(HC) and exercise alone (HE) resulted in ICM and epiblast cell
number not different to CC (p.0.05, Table 2). There was no
Table 1. The Effect of Diet and Exercise of Obese Males on
Embryo Development.
Diet/
Intervention CC HH HC HE HCE
Day 2
Cleavage 88.665.3 88.964.7 89.262.5 90.363.7 94.366.2
Day 3
8 cell/
compacting
71.465.2a 54.2. 65.5b 58.26
5.4b
64.364.9ab 72.065.6a
Compacting 14.763.7ab 15.763.9ab 9.663.7a 8.463.5a 22.264.0b
Day 4
Total
blastocyst
75.565.0 74.165.3 74.765.1 82.264.7 86.265.4
Early
blastocyst
10.363.6a 20.764.1b 13.86
3.8ab
16.163.0ab 12.263.5ab
Expanded
blastocyst
27.363.1a 21.363.2ab 14.06
3.1b
13.962.9b 14.463.3b
Hatching
blastocyst
45.365.0ab 34.365.3b 47.965.1ac 53.064.7ac 59.265.4c
Day 5
Total
blastocyst
86.464.5 83.164.7 83.264.5 84.164.2 87.564.8
Expanded
blastocyst
19.663.6 21.163.8 16.563.7 10.963.4 12.363.9
Hatching
blastocyst
65.265.0ab 55.465.3a 61.96
4.9ab
72.464.7b 74.565.6b
Embryo development is expressed as percentage of embryos 6 SEM at each
stage of development per father. Data represents 6 HH and HCE males and 7
CC, HC and HCE males which is representative of at least 300 embryos per
treatment group (for exact breakdown of embryos per father see Table S2). On
day 4 total blastocysts is made up of early, expanded and hatching blastocysts,
while on day 5 of on time embryo development total blastocyst is made up of a
combination of expanded and hatching blastocysts. Different letters denote
significance at p,0.05.
doi:10.1371/journal.pone.0071459.t001
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change in the proportion of cells or percentage of cells allocated to
the trophectoderm, ICM or epiblast between any of the treatment
groups (p.0.05, Table 2).
Effect of Diet and Exercise on Embryo Cell to Cell Contact
To further evaluate the effect of intervention treatments on rates
of compaction after embryonic genome activation (after 2-cell
stage) and therefore activation of the paternal contribution to the
embryo, the localisation of E-cadherin (a marker of cell to cell
contact) and one of the first paternally translated proteins within
the developing 8-cell embryo [30], was assessed. CC and HE
males had more 8-cell embryos with E-cadherin located at cell to
cell contacts, compared with the other treatment groups (HH, HC
and HCE, p,0.05, Fig. 2A). HCE males had more 8-cell embryos
with E-cadherin located to both cell to cell contacts and cytoplasm
compared with CC and HE males (p,0.05, Fig. 2B), but similar
numbers compared with HH or HC males (p.0.05, Fig. 2B). HC
males had more 8-cell embryos with E-cadherin located to the
cytoplasm compared with HCE males (p,0.05, Fig. 2C). There
was no change to the proportion of 8-cell embryos with E-cadherin
located to the cytoplasm between the remaining treatment groups
(HH, HC, HE, p.0.05, Fig. 2C).
Effect of Diet and Exercise on Implantation and Fetal
Viability
Blastocyst viability was assessed by transferring embryos to
recipient mothers. Blastocysts produced from HH had reduced
implantation rates compared with blastocysts from CC (p,0.05,
Table 3). The combined diet and exercise intervention (HCE) was
the only intervention to improve implantation rates compared
with HH (p= 0.08, Table 3) with diet alone (HC) and exercise
alone (HE) showing no improvements. There was no difference in
fetal development, as assessed by the number of viable fetuses per
the total number of blastocyst transferred, between any of the
treatment groups (p.0.05, Table 3). Exercise intervention alone
(HE) increased the percentage of implantations that resulted in
viable fetuses, compared with CC and diet intervention alone (HC)
(p,0.05, Table 3), with the remaining groups (HH and HCE)
showing no change. HH had decreased fetal weights, lengths and
placental weight compared with CC (p,0.05, Table 3). Any form
of diet and/or exercise intervention (HC, HE, HCE) increased
fetal weights compared with HH (HE and HCE p,0.05 and HC
p=0.08, Table 3); with diet alone (HC) and exercise alone (HE)
additionally increasing crown-rump length compared with HH
(p,0.05, Table 3). There was no change in placental weights
between treatment groups (HC, HE and HCE) and HH (p.0.05,
Table 3), however exercise alone did decrease placental weights
compared with CC (p= 0.08, Table 3). There was no change in
fetal to placenta weights ratio between any of the groups (p.0.05,
Table 3).
Associations between Paternal Metabolic and Hormonal
state and Embryo and Fetal Growth and Development
Diet interventions (HC and HCE) reduced founder male body
weight (HC 22.3760.79 g and HCE 23.1960.75 g), levels of
adiposity (p,0.01), serum cholesterol (p,0.05), serum leptin
(p,0.05), increased lean mass (p,0.05) and improved glucose
tolerance (p,0.05) but maintained insulin resistance as measured
by AAC compared with HH males (Table S3 and Table S4).
Those receiving exercise intervention alone (HE) maintained their
pre intervention body weight (20.2860.75 g) and level of
adiposity (Table S3) with serum cholesterol and insulin resistance
remaining comparable to HH males (p.0.05, Table S4) however,
had a significant reduction in serum leptin levels (p,0.05,
Table S4). Interventions including exercise (HE and HCE)
reduced fasting serum glucose (HE p,0.05 and HCE p=0.08)
with an increased clearance of glucose after a GTT compared with
HH males (p,0.05, Table S4).
Associations with metabolic and hormonal measures in founder
males with embryo and fetal outcomes were further examined to
identify any potentially influential factors due to the differences in
embryo and fetal health observed in the intervention combina-
tions. Paternal serum cholesterol correlated negatively with
blastocyst cell number on day 5 (CCO 20.17, p = 0.01, n = 191)
and day 6 embryos (CCO 20.52, p,0.01, n = 216), as well as TE
cell number (CCO 20.54, p,0.01, n= 216), but positively with
the percentage of DNA damaged cells in blastocysts (CCO 0.42,
p = 0.01, n = 191). Paternal serum FFA correlated negatively with
fetal to placental weight ratio (CCO 20.30, p = 0.01, n= 64) and
percentage of ICM cells (CCO 20.50, p = 0.01, n = 210), but
Table 2. The Effect of Diet and Exercise of Obese Males on Blastocyst Development.
Diet/Intervention CC HH HC HE HCE
Day 5
Total cell number 76.763.8a 64.363.6b 75.364.2a 74.963.5a 86.665.7a
TUNEL positive cells 3.7361.10 4.5461.00 3.5060.87 3.7660.87 3.5960.50
DNA damage (%) 4.8661.38 7.0361.60 4.6561.15 5.0161.12 4.1560.51
Day 6
Total cell number (TCN) 98.366.3a 84.067.6b 100.063.7a 96.363.5a 99.766.2a
Trophectoderm cell number 83.465.5a 72.167.3b 86.661.3a 83.263.7a 85.665.3a
ICM cell number 15.061.29a 12.061.04b 12.961.05ab 13.660.53ab 14.261.04a
Epiblast cell number 7.260.71a 5.760.80b 6.260.73ab 6.260.45ab 6.660.84ab
Trophectoderm (% of TCN) 84.760.96 85.461.48 86.660.78 85.660.95 85.560.64
ICM (% of TCN) 15.360.96 14.861.41 13.461.39 14.460.95 14.560.64
Epiblast (% of ICM) 46.264.50 46.765.99 47.163.63 46.663.90 45.763.37
Data is expressed as mean 6 SEM per father. Data represents 6 HH and HCE males and 7 CC, HC and HCE males which is representative of 5–8 embryos per father per
group. Different letters denote significance at p,0.05.
doi:10.1371/journal.pone.0071459.t002
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positively with the ratio of epiblast cells to ICM cells (CCO 0.51,
p,0.01, n= 209) and the percentage of TE cells (CCO 0.51,
p,0.01, n= 216). Paternal serum triglyceride correlated negative-
ly with both total cell number (CCO 20.44, p,0.01, n = 216) and
TE cell numbers (CCO 20.41, p,0.01, n= 216). Paternal insulin
sensitivity (as measured by AAC during ITT) correlated negatively
with the percentage of TE cells (CCO 20.44, p,0.01, n = 216)
and percentage of DNA damaged cells in blastocysts (CCO20.20,
p,0.01, n = 191), but positively with the percentage of ICM cells
(CCO 0.43, p,0.01, n= 210). Paternal fasting serum glucose
correlated negatively with fetal to placental weight ratio (CCO
20.36, p,0.01, n= 64) and positively with placental weight (CCO
0.21, p= 0.05, n= 64). Additionally paternal adiposity correlated
negatively with both TCN (CCO 20.51, p,0.01, n= 216) and
TE cell number (CCO 20.49, p,0.0, n= 216) and positively with
the percentage of DNA damaged cells in blastocysts (CCO 0.31,
p = 0.03, n= 191).
When controlled for paternal adiposity the majority of the
above correlations still held, indicating that paternal lipid status,
glycaemia and insulin sensitivity are correlated to embryo and fetal
health independently of paternal adiposity (Table S5).
Discussion
There is emerging evidence that paternal obesity and related
metabolic changes are associated with reduced embryo develop-
ment and pregnancy establishment in both humans and rodent
models [5–7,15,16,31]. Here we show for the first time, using a
well characterised model of diet induced obesity in the mouse, that
diet and exercise interventions in the obese father, which either
reduces adiposity or improves their metabolic state at the time of
conception, improves subsequent embryo, pregnancy and fetal
health. Previous studies of interventions to reverse obesity and
metabolic syndrome in males had focused on influences on
restoration of hormone profiles, sperm function and sexual
dysfunction [17,18,32–36], but none had examined effects on
Figure 2. The Effect of Diet and Exercise of Obese Males on E-
cadherin Staining Patterns in Compacting Embryos. A The
percentage of 8 cell embryos with E-cadherin localised to cell to cell
contacts. B The percentage of 8 cell embryos with E-cadherin localised
to both cell to cell contacts and cytoplasm. C The percentage of 8 cell
embryos with E-cadherin localised to the cytoplasm. Date represents 3
HH, HCE and 4 CC, HC and HE males which is representative of 3–7
embryos per father per group.
doi:10.1371/journal.pone.0071459.g002
Table 3. The Effect of Diet and Exercise of Obese Males on
Subsequent Implantation and Fetal Development.
Diet/
Intervention CC HH HC HE HCE
Implantation
(%)
98.5a 83.3b 85.9bc 84.7bc 93.1acˆ
Fetal (%) 15.3 23.6 14.4 26.4 16.0
Fetal/
Implantation (%)
14.5a 24.2ab 14.6a 27.7b 15.9ab
Fetal
weight (mg)
773631a 701628b 776642aˆ 816638a 818631a
Crown-Rump
length (mm)
18.460.4a 17.460.3b 18.660.5a 18.560.3a 18.060.4ab
Placental
weight (mg)
11363a 10266b 10968ab 10465b* 102610ab
Fetal:
placenta ratio
6.860.5 7.060.5 7.360.3 7.760.3 7.460.2
Data is expressed as mean 6 SEM per father. Implantation and fetal
development data represents 5 HE and HCE and 6 CC, HH and HC males which
is representative of 12–18 embryos transferred per father for each group. Fetal
and placenta data represents 5 HE and HCE and 6 CC, HH and HC males which is
representative of at least 10 fetuses per treatment group (for exact breakdown
of number of fetuses per father see Table S2). Different letters denote
significance at p,0.05.ˆdifferent to HH at p = 0.08 and *different to CC at
p = 0.08.
Implantation (%) refers to the percentage of blastocyst that implanted into the
uterus resultant from total number of embryos transferred determine by fetal
numbers and resorptions. Fetal (%) refers to the percentage of embryos that
formed fetus resultant for the total number of embryos transferred. Fetal/
implantation (%) refers to the percentage of fetuses that formed from the total
number of successful implantations.
doi:10.1371/journal.pone.0071459.t003
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embryo development and pregnancy establishment. Using diet
induced obesity in male mice; we showed that the negative impact
of paternal obesity on blastocyst development, blastocyst cell
numbers, as well as subsequent implantation rate and fetal growth
can be reversed through improvements to paternal metabolic
health via diet and/or exercise. Further, the metabolic status of the
father, including lipid status, glycaemia and insulin sensitivity are
strongly associated with markers of blastocyst and fetal develop-
ment or growth, independently of paternal adiposity or exposure
to dietary or exercise interventions.
It has previously been shown and confirmed by this study that
males fed a HFD produce embryos that have delayed develop-
ment, with longer times to 1st, 2nd and 3rd cleavage and cavitation
[11,31] with a reduction in the numbers of on time developing
embryos at the compacting, early blastocyst and late blastocyst
stage [15]. Here we show for the first time that improvements to
adiposity and metabolism via diet and/or exercise improve
embryo development rates and blastocyst cell numbers in previous
obese male mice. Specifically, the improved embryo development
seen by those mice that underwent interventions involving exercise
(HE and HCE) was evident after activation of the embryonic
genome (in the mouse at the 2-cell stage); with more embryos
reaching the 8 cell/compacting stage on day 3 and similarly for
blastocysts on day 4 and day 5. In humans it has been shown that
embryos that have successful implantation develop to the 8 cell
stage faster than those embryos that couldn’t implant [37]
suggestive of improved implantation capability of embryos
produced from exercise males.
Furthermore, we also confirmed the reductions in blastocyst cell
numbers, including reduced numbers of ICM and TE cells, which
have been observed from males fed a HFD [11,15]. All diet and
exercise interventions in obese male mice, increased blastocyst
total cell numbers on both day 5 and day 6 of in vitro embryo
development with improvements to both TE and to a lesser extent
ICM cells. The late blastocyst is made up of two main cell types: 1;
trophectoderm cells, which are necessary for embryo implantation
and invasion and the establishment of the placenta; and 2; ICM
cells, which can be split into epiblast cells that form the fetus and
the primitive endoderm, that forms the extra embryonic tissue
[38]. Changes to the numbers of cells or the distribution of the
cells within the blastocyst can adversely affect the developing fetus,
for an example, a reduction in numbers of ICM cells in a maternal
diabetic rat model associated with fetal growth restriction [39].
Additionally in rodents blastocyst cell numbers as well as the
proportion of cells within the late blastocysts have also been shown
to positively correlate with implantation and pregnancy rates [26].
This suggests that exercise and diet intervention in obese males
could potentially improve implantation and live birth rates, by
restoring cell allocation and mitosis in the blastocyst.
In a clinical ART setting, obese males are associated with an
increased rate of miscarriage, which may be as a result of sac only
pregnancies [5] implying that cells within the embryo that form
the fetus (i.e. epiblast cells) are impaired or missing. Here we
directly show for the first time that diet induced obesity reduces the
number of epiblast cells within the developing embryo and could
potentially provide an explanation for the increased miscarriage
rate seen in association with obese men [5–7]. Although diet and/
or exercise interventions did not significantly improve epiblast cells
number compared with HFD (HH) or CD (CC) they were still
slightly increased compared to HFD mice, again suggesting likely
improvements to implantation and pregnancy establishment.
Previous studies have also shown that blastocyst apoptosis is
another marker of embryo health, with increasing apoptosis
associated with reduced embryo survival, implantation rates and
increases in early miscarriage [40–43]. Interestingly, in the current
study, no differences were observed in relation to the levels of
blastocyst apoptosis between the diet and exercise interventions or
between HFD (HH) and CD (CC). This is contradictory to those
findings found in Mitchell et al [15], where male mice fed a HFD
for a period of 8 weeks showed increased rates of apoptosis in the
late blastocysts. The differences in outcomes with the current study
could be strain (C57BL6 compared with C57BL6xCBAF1) and
age specific (23 weeks of age compared with 13 weeks) or related
to the increased length of exposure to both the CD and HFD diets
in the current study versus the previous study (18 weeks compared
with 8 weeks).
The current study showed for the first time that diet induced
obesity in resulted in changed localisation patterns of E-cadherin
in compacting embryos, with more 8 cells having E-cadherin
located in the cytoplasm from males fed a HFD, indicating a
potential delay in establishment of the junctional communication
between the blastomeres. However this potential delay was
improved by exercise interventions with increased in E-cadherin
observed in cell to cell contacts from these groups. The process of
compaction in the developing embryo, involves polarisation of the
cells, cell flattening and junctional communication [44]. E-
cadherin is required in the developing embryo for the above
processes, to allow compaction and cell division whilst also
coordinating the cellular allocation and spatial segregation of the
ICM and trophectoderm, with E-cadherin mutants unable to form
a trophectoderm [30,45,46]. During embryo polarisation E-
cadherin moves from the cytoplasm and becomes restricted to
cell to cell contacts where it is stabilised before embryo compaction
[47]. It therefore appears that E-cadherin in embryos localised in
the cytoplasm compared with cell to cell contacts, is indicative of a
delay in this polarisation and compaction. Changes to the
localisation and levels of E-cadherin in compacting embryos
where males were treated with cyclophosphamide [27], resulted in
half of all compacting embryos with little or no cell contacts, with
the immune reactivity of E-cadherin reduced and a significant
delay in embryo development [27]. The improvements seen in
those males that underwent exercise interventions suggests an
advancement in development of compaction which may be
contributing to the improvements in development and cell
numbers seen in embryos derived from these males.
Previous studies in humans undergoing assisted reproductive
technologies suggest that male obesity reduces implantation and
therefore live birth rates [5–7]. Consistent with results observed in
a previous rodent study of male obesity and embryo health
[11,15], the current study confirmed that males fed a high fat diet
for the entire study had reduced implantation rates assessed at day
18 of gestation after embryo transfer, compared with those fed a
CD. Interestingly, only the combined diet and exercise interven-
tion (HCE) group improved implantation rates compared with
males fed a HFD for the entire study. However it should be
mentioned that morphological similar blastocysts from each group
were used in embryo transfers which can predict implantation
rates [37] and suggests that evaluation of a combined approach to
weight loss in a clinical setting to evaluate the impact on
implantation and therefore live birth rates is warranted.
Fetal development and size are not only determinants of a
healthy pregnancy but can also pre determine the likelihood of
developing adult chronic disease [48,49]. Paternal exposure to
high levels of x-rays as well as fathers’ occupation is associated with
small for gestational age babies independently of other confound-
ing factors [50,51], showing that paternal health at the time of
conception can influence fetal health outcomes. Consistent with
previous studies in rodents [11,52] our HFD fed mice (HH)
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produced smaller fetuses compared with those fed a CD (CC),
which has been linked with impaired metabolic and reproductive
health in subsequent offspring [52,53]. Interestingly, all interven-
tions (HC, HE, HCE) increased fetal weights compared to males
fed a HFD (HH) with diet alone (HC) and exercise alone (HE)
additionally increasing fetal lengths. This suggests that offspring
born from obese fathers that underwent diet and/or exercise
interventions may have a reduced susceptibility to develop adult
chronic diseases.
It is becoming increasingly evident that at least some changes to
embryo and fetal health must be resultant from the sperm health
at the time of conception. Previous studies have shown that poor
sperm quality including increased levels of DNA damage and/or
reactive oxygen species are associated with reduced fertilisation,
impaired embryonic development and increased pregnancy loss
[40–43,54–56]. Increased levels of DNA damage and ROS in
sperm are commonly found in obese males [57–59]. Using this
same model it has previously been shown that diet and exercise
interventions reduced both DNA damage and ROS levels in
sperm of obese male mice [13]. The improved embryo and fetal
health seen in the current study may therefore be as a result of
improvements to sperm DNA damage and/or ROS levels in
sperm. In humans, diet and exercise interventions as well as gastric
bypass surgeries have been shown to improve other sperm
measures such as count, motility as well as sexual function in
previously overweight and obese men [17,18]. Further, it has been
shown that the proteomic, microRNA (miRNA) and methylome
content of sperm including the RNA content of testes from obese
rodents are also altered [16,60–64] molecular sperm signatures
that have previously been shown to impact embryo health and
quality [65,66]. This may be contributing to the impaired sperm
and embryo development seen in obese men. It is therefore
possible that improvements to embryo and fetal health seen in the
current study are resultant from additional improvements to sperm
epigenetic molecular structure including changes to histone
methylation and miRNA content. The specific types of molecular
signatures currently altered in sperm as a result of obesity and then
restored by diet and exercise interventions are currently unknown.
However, a recent study in humans showed that miRNAs in
serum previously altered by obesity could be restored through
weight loss [67], suggesting that a similar restoration could likely
occur in sperm and explain the improvements in our study.
As seen in our previous study [13] mice that underwent diet
interventions (HC and HCE) had reduced levels of adiposity,
improved serum cholesterol, FFAs, glucose tolerance and addi-
tionally serum leptin levels. Those receiving exercise intervention
only (HE) were still obese maintaining their pre intervention level
of adiposity, serum cholesterol, and impaired response to insulin,
however had significant reductions in serum leptin levels which are
consistent to findings found previously in obese males [68,69].
Interventions including exercise (HE and HCE) reduced fasting
serum glucose with an increased clearance of glucose after a GTT.
This is likely as a result from increased glucose utilisation by
skeletal muscle (reviewed by [70]). Using association analysis
between the father’s body composition and metabolic parameters,
the data in this study suggests that the adverse embryo and fetal
health due to diet induced obesity may not only be resultant from
increased adiposity but additionally whole body metabolic
changes. Irrespective of father’s treatment or adiposity, carbohy-
drate and lipid profiles showed the strongest correlations to
embryo and fetal health, with reduced cholesterol, and FFAs
associated with improved blastocyst cell numbers and reduced
cellular apoptosis. Additionally, glucose and insulin metabolism
were also found to be associated with improved embryo cell
numbers and fetal and placental weight ratios.
Due to lack of cytoplasmic scavenging enzymes and high levels
of polyunsaturated fatty acids in their plasma membrane, sperm
are highly susceptible to oxidative stress and damage [71–73].
Exposure to increasing levels of both cholesterol and fatty acids in
human and animal sperm in vitro has previously been shown to
cause increased mitochondrial ROS [74] reduced sperm motility,
capacitation and fertilisation [75,76]. In particular, cholesterol is
found in the sperm membrane and its levels within the membrane
affects fluidity and helps determine motility, capacitation and
acrosome reaction [77,78], all important process required for
successful fertilisation [79]. Hypercholesterolemia in rabbits
showed that the transport ion channels were open in the
epididymis between the circulating lipids and the sperm micro
environment [74] and that the sperm from these rabbits displayed
reduced motility and capacitation likely caused from increasing
sperm ROS. It is therefore plausible that high circulating plasma
cholesterol, triglycerides and FFAs as seen in male obesity cause
changes to sperm membrane dynamics and directly alter the
fluidity of the plasma membrane allowing the sperm to be more
susceptible ROS and DNA damage. Increased levels of ROS have
been shown to change the global methylation profile of sperm
[80], with hypomethylation of imprinted genes and repeat
elements in sperm linked with reduced pregnancy success and
increased sperm DNA damage [80–83]. It is therefore, possible
that elevated paternal plasma glucose and lipids may in this way
modifies the epigenetic profile of sperm, which is then passed onto
the newly fertilised embryo, causing a delay in embryo develop-
ment via alterations to paternal chromatin remodelling and
indirectly reducing embryo cell numbers and implantation rates.
This is the first study to show that the impaired embryo and
fetal development commonly seen in obese males can be reversed
by improving their metabolic profile via exercise and diet. This
study also provides the first direct evidence that the metabolic
profile of obese fathers maybe a better indicator for determining
the health of the resultant embryo and fetus than adiposity alone.
Therefore, this study shows that exercise and diet interventions
could be a combined approach to target sub fertility in overweight
and obese men by improving embryo development and therefore
subsequent pregnancy health. Future studies in the human are
needed to determine if similar improvements can occur.
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